First Tracks Biotherapeutics, Inc. TRAX.O: H.C. Wainwright raises target price to $57 from $44
TRAX•Related News
Cellectar Biosciences Q2 net loss widens on higher R&D costs
CLRB•
enCore Energy enters controlled equity offering agreement for up to US$250 million ATM share sale
EU•
Reborn Coffee to improve margins with AI forecasting and in-house logistics through unit
REBN•
Karyopharm Q2 revenue falls as license revenue drops; expects funds to last into September
KPTI•
Creative Realities FY26 Q2 net loss widens to $4.3 million; revenue rises to $21.5 million
CREX•